Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Grelan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grelan Pharmaceutical Co LtdfiledCriticalGrelan Pharmaceutical Co Ltd
Priority to JP13239179ApriorityCriticalpatent/JPS5657713A/en
Publication of JPS5657713ApublicationCriticalpatent/JPS5657713A/en
PURPOSE: To provide an immunoactivating agent containing a sulfylimine compound as an effective component, and useful as an agent for immunotherapy or a remedy for infectious diseases, autoimmune diseases, etc.
CONSTITUTION: An agent containing, as an effective component, a compound of formula I [R1 and R2 are aryl, substituted aryl, or alkyl; R1 and R2 may be bonded together with methylene group or O atom; R3 is H or group of formula II (R4 and R5 are H or lower alkyl)], e.g. phenyl o-methoxyphenylsulfylimine. Daily dose for adult: 1W600mg by oral or parenteral administration.
5-ALKYL-1-PHENYL-2-PIPERAZINOALKYLPYRAZOLINE-3-ON COMPOUNDS AND METHODS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.
3-(2-(AZABICYCLO)ETHYL)1,2,3,4-TETRAHYDRO-5H(1)BENZOPYRAN(3,4-C)PYRIDIN-5-ONE, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESSES FOR THEIR MANUFACTURE.